Acute Promyelocytic Leukemia — Trials

Acute Promyelocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01548911	Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia	withdrawn	Phase 2	0	Wake Forest University Health SciencesOTHER	0	Jul 2, 2018	clinicaltrials
NCT00670150	New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia	withdrawn	Phase 2	0	University of Southern CaliforniaOTHER	1	Oct 27, 2015	clinicaltrials